Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Prolactin receptor antagonists

C B Kuo1, D Coss, A M Walker

  • 1Division of Biomedical Sciences, University of California, Riverside 92521-0121, USA.

Endocrine
|December 29, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adolescent ethanol exposure reprograms HMGB1 responsivity to adult ethanol challenge in males.

Physiology & behavior·2026
Same author

Computed tomography versus radiography for assessment of canine humeral condylar fracture malreductions.

New Zealand veterinary journal·2025
Same author

Development of a novel Bluetooth Low Energy device for proximity and location monitoring in grazing sheep.

Animal : an international journal of animal bioscience·2024
Same author

Neuroprotection by anaesthetics in rodent models of traumatic brain injury: a systematic review and network meta-analysis.

British journal of anaesthesia·2018
Same author

Point-of-care paediatric gastric sonography: can antral cut-off values be used to diagnose an empty stomach?

British journal of anaesthesia·2017
Same author

The kinematics and kinetics of riding a racehorse: A quantitative comparison of a training simulator and real horses.

Journal of biomechanics·2016
Same journal

Effects of a single-dose denosumab on glucose and lipid homeostasis in young infertile men.

Endocrine·2026
Same journal

Ultrasound-guided thermal ablation for papillary thyroid microcarcinoma with calcifications: short-term imaging outcomes.

Endocrine·2026
Same journal

Diabetic gastroparesis: pathophysiology and impact on insulin timing choices.

Endocrine·2026
Same journal

Liquid biopsies for BRAF V600E assessment and monitoring in anaplastic thyroid carcinoma: a real-world study of a tertiary cancer center.

Endocrine·2026
Same journal

Interpreting the TIR 3B nomogram as a rule-in rather than rule-out tool.

Endocrine·2026
Same journal

Clinical and laboratory characteristics of pediatric patients diagnosed with thyroid hormone resistance: A single-center experience.

Endocrine·2026
See all related articles

Researchers are exploring prolactin (PRL) receptor antagonists to understand local PRL production in tissues. These agents could reveal the role of extrapituitary prolactin in health and disease, potentially leading to new therapies.

Area of Science:

  • Endocrinology
  • Molecular Biology
  • Pharmacology

Background:

  • Pituitary gland is the primary source of circulating prolactin (PRL).
  • Various peripheral tissues also produce local prolactin, potentially acting via autocrine/paracrine mechanisms.
  • Current methods using dopamine agonists primarily assess pituitary PRL effects, limiting the study of local PRL actions.

Purpose of the Study:

  • To critically review prolactin-receptor interactions and signaling pathways.
  • To describe the development of growth hormone (GH) and prolactin receptor (PRLR) antagonists.
  • To investigate the role of extrapituitary prolactin in normal physiology and disease using PRLR antagonists.

Main Methods:

  • Review of existing literature on PRL-receptor interactions and signaling.

Related Experiment Videos

  • Development and application of PRLR antagonists.
  • Analysis of signal transduction mechanisms, including receptor dimerization models.

    • Main Results:

    • PRLR antagonists are crucial tools for dissecting the functions of locally produced prolactin.
    • Extrapituitary prolactin plays a role in both normal tissue function and disease pathogenesis.
    • A potent PRL antagonist was used to investigate PRLR signaling, questioning simple dimerization models.

    Conclusions:

    • PRLR antagonists offer a novel approach to study and potentially treat diseases involving local prolactin.
    • Understanding extrapituitary prolactin's role is vital for developing targeted therapeutics.
    • Further research is needed to fully elucidate PRLR signal transduction pathways.